Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

2,5-Dimethoxy-4-isopropylamphetamine

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
DOiP
Clinical data
Other namesDOiP; DOiPr
Legal status
Legal status
Identifiers
  • 1-[2,5-Dimethoxy-(propan-2-yl)phenyl]propan-2-amine
CAS Number
PubChemCID
ChemSpider
UNII
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC14H23NO2
Molar mass237.343 g·mol−1
3D model (JSmol)
  • COC1=C(C=C(C(=C1)C(C)C)OC)CC(C)N
  • InChI=1S/C14H23NO2/c1-9(2)12-8-13(16-4)11(6-10(3)15)7-14(12)17-5/h7-10H,6,15H2,1-5H3
  • Key:UEEAUFJYLUJWQJ-UHFFFAOYAM

2,5-Dimethoxy-4-isopropylamphetamine (also known asDOiP andDOiPr) is apsychedelicdrug of thephenethylamine andamphetaminechemical classes.[1][2][3] It was firstsynthesized byAlexander Shulgin, and was described in his bookPiHKAL (Phenethylamines i Have Known And Loved). Shulgin described DOiPR as being at least an order of magnitude weaker thanDOPR, with doses of 20–30 mg required to produce valid changes in mental state.[4] Very little data exists about the pharmacological properties, metabolism, and toxicity of DOiP. DOiP substitutes forDOM in rodentdrug discrimination tests, but is several-fold lesspotent than other DOx drugs likeDOM,DOET, and DOPR, though it is similar in potency toDOBU.[5]

See also

[edit]

References

[edit]
  1. ^Glennon RA, Seggel MR (November 1989). "Interaction of phenylisopropylamines with central 5-HT2 receptors. Analysis by quantitative structure-activity relationships.".Probing Bioactive Mechanisms. ACS Symposium Series. Vol. 413. pp. 264–280.doi:10.1021/bk-1989-0413.ch018.ISBN 978-0-8412-1702-7.
  2. ^Seggel MR, Yousif MY, Lyon RA, Titeler M,Roth BL, Suba EA, Glennon RA (March 1990). "A structure-affinity study of the binding of 4-substituted analogues of 1-(2,5-dimethoxyphenyl)-2-aminopropane at 5-HT2 serotonin receptors".Journal of Medicinal Chemistry.33 (3):1032–6.doi:10.1021/jm00165a023.PMID 2308135.
  3. ^Aldous FA, Barrass BC, Brewster K, Buxton DA, Green DM, Pinder RM, et al. (October 1974). "Structure-activity relationships in psychotomimetic phenylalkylamines".Journal of Medicinal Chemistry.17 (10):1100–11.doi:10.1021/jm00256a016.PMID 4418757.
  4. ^Shulgin A, Shulgin A (September 1991)."PiHKAL: A Chemical Love Story #71 DOPR". Transform Press. p. 978. Retrieved27 June 2015.
  5. ^Glennon RA (1989)."Stimulus properties of hallucinogenic phenalkylamines and related designer drugs: formulation of structure-activity relationships"(PDF).NIDA Res Monogr.94:43–67.PMID 2575229. Archived fromthe original(PDF) on May 11, 2023.
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
  • Bioisosteres:JRT
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds


Stub icon

Thishallucinogen-related article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=2,5-Dimethoxy-4-isopropylamphetamine&oldid=1322813335"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp